BRAF and neoplasm: Accordingly in that study, neither the PERK nor ATF6 branches were involved but interestingly, IRE1α inhibition was required for engaging immunogenic cell death in the BRAF-mutant setting, showing how IRE1α mediates tumor resistance through immune evasion.